Prices are updated after-hours



nasdaq:PXHI usell.com, Inc.

PXHI | $1.1 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (-9.8% 1m) (35.8% 1y) (0.0% 2d) (0.0% 3d) (-8.3% 7d) (53.85% volume)
Earnings Calendar:
Market Cap: $ 40,564,128

http://www.usell.com/
Sec Filling | Patents | 88 employees


(US) Upstart is a leading AI lending platform partnering with banks to expand access to affordable credit.



add to watch list email alert is off

nasdaq:HHS HARTE HANKS INC

HHS | $11.47 6.5% 0.0% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (2.3% 1m) (33.0% 1y) (0.0% 2d) (0.0% 3d) (1.7% 7d) (1.82% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 80,521,728

https://www.hartehanks.com/
Sec Filling | Patents | 2131 employees


(US) Harte Hanks is a leading global customer experience company whose mission is to partner with clients to provide them with CX strategy, data-driven analytics and actionable insights combined with seamless program execution to better understand, attract, and engage their customers. Using its unparalleled resources and award-winning talent in the areas of Customer Care, Fulfillment and Logistics, and Marketing Services, Harte Hanks has a proven track record of driving results for some of the world's premier brands including Bank of America, GlaxoSmithKline, Unilever, Pfizer, HBOMax, Volvo, Ford, FedEx, Midea, Sony and IBM among others. Headquartered in Austin, Texas, Harte Hanks has over 2,500 employees in offices across the Americas, Europe, and Asia Pacific.



add to watch list email alert is off

Monte Rosa Therapeutics Inc

GLUE | $9.13 -3.18% 0.0% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (18.6% 1m) (-48.2% 1y) (0.0% 2d) (0.0% 3d) (6.1% 7d) (25.83% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 441,883,381

https://www.monterosatx.com
Sec Filling | Patents | 60 employees


Monte Rosa Therapeutics is a biotechnology company discovering and developing molecular glues to degrade disease-causing proteins. The company has created a platform to rationally design small molecules that reprogram ubiquitin ligases to eliminate disease drivers previously deemed undruggable. The company’s drug discovery platform combines diverse and proprietary chemical libraries of small molecule protein degraders with in-house proteomics, structural biology, machine learning-based target selection and computational chemistry capabilities to predict and obtain protein degradation profiles. Monte Rosa was launched from founding investor Versant Ventures’ Ridgeline Discovery Engine and is headquartered in Boston, Mass., with research operations in both Boston and Basel, Switzerland.

drug discovery   profitable  

add to watch list email alert is off

nasdaq:EDNMY Edenred/ADR

EDNMY | $27.3 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (0.7% 1m) (21.3% 1y) (0.0% 2d) (0.0% 3d) (-1.3% 7d) (-91.15% volume)
Earnings Calendar:
Market Cap: $ 13,627,508,021

https://www.edenred.com/
Sec Filling | Patents | n/a employees


(FR)



add to watch list email alert is off

nasdaq:WYGPY Worleyparsons Ltd/ADR

WYGPY | $9.59 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (0.5% 1m) (29.6% 1y) (0.0% 2d) (0.0% 3d) (-1.4% 7d) (37.2% volume)
Earnings Calendar:
Market Cap: $ 5,035,283,166

https://www.worley.com/
Sec Filling | Patents | n/a employees


(AU)



add to watch list email alert is off

nasdaq:JGCCY JGC Corp

JGCCY | $26.28 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (-3.5% 1m) (48.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (99.47% volume)
Earnings Calendar:
Market Cap: $ 3,408,646,428

https://www.jgc.com/
Sec Filling | Patents | n/a employees


(JP)



add to watch list email alert is off

Beauty Health Company (The) - Class A

SKIN | $10.89 -1.27% 2.45% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (3.1% 1m) (-56.3% 1y) (0.0% 2d) (0.0% 3d) (1.5% 7d) (-14.69% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 1,559,459,336

https://www.beautyhealth.com/
Sec Filling | Patents | n/a employees


BeautyHealth is a category-creating beauty health company focused on bringing innovative products to market. Its flagship brand, HydraFacial, is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. Leading the charge in beauty health as a category-creator, HydraFacial uses a unique delivery system to cleanse, extract, and hydrate with their patented hydradermabrasion technology and super serums that are made with nourishing ingredients, providing an immediate outcome and creating an instantly gratifying glow in just three steps and 30 minutes. HydraFacial® and Perk™ products are available in over 87 countries with over 16,000 delivery systems globally and millions of treatments performed each year.

brands   msa   skin   treatment   3d  

add to watch list email alert is off

Finch Therapeutics Group Inc

FNCH | $0.93 -2.13% 0.0% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (-12.0% 1m) (-92.0% 1y) (0.0% 2d) (0.0% 3d) (2.2% 7d) (80.31% volume)
Earnings Calendar: 2022-11-09
Market Cap: $ 44,544,838

https://finchtherapeutics.com
Sec Filling | Patents | n/a employees


Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted microbiome therapeutics, Finch is advancing a rich pipeline of candidates designed to address a wide range of unmet medical needs. Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. Finch plans to initiate a Phase 3 trial, referred to as PRISM4, as its second pivotal trial of CP101 for recurrent CDI. Finch is also developing CP101 for the treatment of chronic hepatitis B virus, and FIN-211 for the treatment of the gastrointestinal and behavioral symptoms of autism spectrum disorder. In partnership with Takeda, Finch is advancing FIN-524 and FIN-525 for the treatment of ulcerative colitis and Crohn’s disease, respectively.

hepatitis   gastrointestinal   treatment   injection  

add to watch list email alert is off

nasdaq:ECOX ECO INNOVATION GROUP, INC.

ECOX | $0.0005 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (-16.7% 1m) (-95.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-87.92% volume)
Earnings Calendar:
Market Cap: $ 548,142


Sec Filling | Patents | n/a employees






add to watch list email alert is off

3D MAKERJET, INC.

FKST | $1.7 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (0.0% 1m) (-58.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (199.0% volume)
Earnings Calendar:
Market Cap: $ 221,360


Sec Filling | Patents | n/a employees






add to watch list email alert is off

nasdaq:ADSV Allied Security Innovations, Inc.

ADSV | $0.0002 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-99.87% volume)
Earnings Calendar:
Market Cap: $ 82,248


Sec Filling | Patents | 2016 employees






add to watch list email alert is off

Quantum-Si Incorporated - Class A

QSI | $2.3 -2.54% 0.42% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (-8.5% 1m) (-64.7% 1y) (0.0% 2d) (0.0% 3d) (-5.6% 7d) (-13.16% volume)
Earnings Calendar: 2022-11-07
Market Cap: $ 275,727,439

https://quantum-si.com
Sec Filling | Patents | 115 employees


Quantum-Si Incorporated develops protein sequencing platform. The Company offers semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

drug discovery   diagnostics  

add to watch list email alert is off

nasdaq:IGPK Integrated Cannabis Solutions, Inc.

IGPK | $0.0016 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (-15.8% 1m) (-50.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-74.25% volume)
Earnings Calendar:
Market Cap: $ 2,973,307


Sec Filling | Patents | 1 employees


(US)



add to watch list email alert is off

Codex DNA Inc

DNAY | $1.34 0.0% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (-19.8% 1m) (-81.7% 1y) (0.0% 2d) (0.0% 3d) (-1.5% 7d) (-2.91% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 39,559,154

https://codexdna.com
Sec Filling | Patents | 101 employees


Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development, and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.

vaccine  

add to watch list email alert is off

nasdaq:INTI Inhibitor Therapeutics, Inc.

INTI | $0.067 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (1.9% 1m) (-62.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-97.55% volume)
Earnings Calendar:
Market Cap: $ 25,249,508

http://www.hedgepathpharma.com/
Sec Filling | Patents | 2 employees


(US)



add to watch list email alert is off

:EQRX EQRx Inc

EQRX | $ 0% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0% volume)
Earnings Calendar:
Market Cap:


Sec Filling | Patents | n/a employees






add to watch list email alert is off

AccuStem Sciences Ltd

ACMSY | $0.13 0% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (4.0% 1m) (-31.6% 1y) (4.0% 2d) (4.0% 3d) (0.0% 7d) (13.9% volume)
Earnings Calendar:
Market Cap:


Sec Filling | Patents | n/a employees






add to watch list email alert is off

Design Therapeutics Inc

DSGN | $13.52 -1.1% 0.0% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (-11.1% 1m) (-26.3% 1y) (0.0% 2d) (0.0% 3d) (-2.1% 7d) (-4.02% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 755,904,160

https://www.designtx.com
Sec Filling | Patents | n/a employees


Design Therapeutics is a biotechnology company developing a new class of therapies based on a platform of gene targeted chimera (GeneTAC™) small molecules. The company’s lead program is focused on the treatment of Friedreich ataxia, followed by a program in myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions.

treatment  

add to watch list email alert is off

nasdaq:CTAGY Capita Group/ADR

CTAGY | $1.17 | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (0.0% 1m) (-53.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-54.67% volume)
Earnings Calendar:
Market Cap:

https://www.capita.com/
Sec Filling | Patents | n/a employees


(United Kingdom)



add to watch list email alert is off

nasdaq:CRXM Gene Biotherapeutics, Inc.

CRXM | $0.0001 0% | twitter stocktwits trandingview |
Professional, Scientific, and T...

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-70.0% volume)
Earnings Calendar:
Market Cap:

http://www.cardiumthx.com/
Sec Filling | Patents | n/a employees


(US)



add to watch list email alert is off

Your Today's Watch List
Sign in to create a watchlist
Top 10 Gainers
SLQT 4 | $0.5733 -7.08% 18.61% | twitter stocktwits trandingview |
Finance

MSC | $3.98 21.01% 11.81% | twitter stocktwits trandingview |
Consumer Services

CCM | $1.63 9.82% | twitter stocktwits trandingview |
Health Services

UPH 4 | $0.2341 -28.85% 8.93% | twitter stocktwits trandingview |
Professional, Scientific, and T...

ID 4 | $1.08 -6.09% 8.8% | twitter stocktwits trandingview |
Finance

DTC 4 | $4.28 -2.51% 8.41% | twitter stocktwits trandingview |
Manufacturing

IMH | $0.231 -5.64% 8.23% | twitter stocktwits trandingview |
Finance

IGC | $0.4095 -9.0% 7.2% | twitter stocktwits trandingview |
Health Technology

GROY | $2.56 -1.16% 6.48% | twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...

GLDG | $1.24 -12.06% 6.45% | twitter stocktwits trandingview |
Non-Energy Minerals


Last 48 Hours Insiders Buying
BOXL P 32000 | $0.3124 -12.98% 2.51% | twitter stocktwits trandingview |
Commercial Services
| 01:00
FRST P | $12.12 0.0% | twitter stocktwits trandingview |
Finance and Insurance
| 00:30
SDPI P 16279 | $0.8052 -1.2% -0.65% | twitter stocktwits trandingview |
Industrial Services
| 23:00
STRR P 10000 | $0.97 3.09% | twitter stocktwits trandingview |
Manufacturing
| 23:00
PED P 76746 | $1.1 0.0% | twitter stocktwits trandingview |
Industrial Services
| 22:50
KRO P 2000 | $9.57 1.59% 0.0% | twitter stocktwits trandingview |
Process Industries
| 22:00
NL P 2000 | $6.75 -1.6% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing
| 22:00
IDN P 1796 | $2.08 0.0% | twitter stocktwits trandingview |
Electronic Technology
| 22:00
VHI P 1000 | $23.75 -4.89% 0.0% | twitter stocktwits trandingview |
Process Industries
| 22:00
RHE P 7200 | $2.69 1.32% 0.37% | twitter stocktwits trandingview |
Finance
| 21:50
CIX P 1000 | $18.6 -2.26% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing
| 21:50
FMBM P 54 | $22.69 | twitter stocktwits trandingview |
Finance and Insurance
| 21:10
HSON P 1000 | $24.99 -0.28% 0.0% | twitter stocktwits trandingview |
Commercial Services
| 21:10
ELA P 2500 | $5.23 -0.95% 0.19% | twitter stocktwits trandingview |
Retail Trade
| 17:30
NYCB P 6000 | $8.63 1.17% -0.7% | twitter stocktwits trandingview |
Finance
| 16:50
HPKEW 4 | $16.2197 0% | twitter stocktwits trandingview |
Industrial Services
| 23:50

12 months watchlist earnings calendar